Real-World Outcomes of Dedicated Leaflet Modification for Bioprosthetic Valve-In-Valve TAVR: A 150-Patient Commercial Experience

Hypertension

Real-World Experience with Selexipag in Patients with Pulmonary Arterial Hypertension: Treatment Patterns and Outcomes across Baseline Risk Strata (SPHERE and EXPOSURE Studies)

Drugs Real World Outcomes

Escribano Subias P, Chakinala MM, Chin KM, Didden EM, Doad G, Farber HW, Gaine S, Hemnes AR, Highland KB, Lange TJ, McLaughlin V, Muller A, Rahman M, Remeňová T, Söderberg S, Venkatesh A, Kim NH

doi: 10.1007/s40801-025-00536-4

Atrial Fibrillation

Atrial fibrillation recurrence and outcomes in patients with hypertrophic cardiomyopathy: Insights from a nationwide real-world cohort

Heart Rhythm

Aglan A, Fath AR, Silver JS, Harnish P, Hook B, Maron MS, Rowin EJ

doi: 10.1016/j.hrthm.2026.03.1906

Therapy and InterventionFurther Publications

Valve-in-Valve Transcatheter Mitral Valve Replacement Versus Redo Surgical Mitral Valve Replacement: Meta-Analysis of Early and Late Outcomes

J Am Heart Assoc

Sá MP, Neves G, Consoli L, Iqbal A, Dexheimer L, da Hora DAB, Camarotti T, Jacquemyn X, Napoli F, Polanco A, Brozzi NA, Navia JL

doi: 10.1161/JAHA.126.050299

Heart, Artery and Coronary Diseases

Mavacamten Monotherapy in Real-World Patients with Obstructive Hypertrophic Cardiomyopathy: Evidence From COLLIGO-HCM

Circ Genom Precis Med

Bilen O, Adler AS, Bastiaenen R, MacNamara JP, Paratz ED, Maor E, Arad M, Gold ME, Patel N, Pruett C, Burford E, Arora G, Maksabedian Hernandez EJ, Han X, Schuler P, Sandler B, Li L, Tian D, Arora P

doi: 10.1161/CIRCGEN.125.005502

Heart, Artery and Coronary DiseasesTherapy and Intervention

Health Status Outcomes 7 Years After Transcatheter or Surgical Aortic Valve Replacement in Low-Surgical Risk Patients With Aortic Stenosis

J Am Coll Cardiol

Brener MI, Cohen DJ, Kodali SK, Hahn RT, Thourani VH, Makkar RR, Pibarot P, Yu X, Lubich B, Mack MJ, Leon MB, Arnold SV

doi: 10.1016/j.jacc.2026.06.022

Heart, Artery and Coronary DiseasesTherapy and Intervention

Real-Time Fluoroscopic Assessment of Underexpansion Predicts Hemodynamic Valve Deterioration Following TAVR With Balloon-Expandable Device

JACC Cardiovasc Interv

Angellotti D, Elamin N, Ferro C, Tomii D, Lanz J, Stortecky S, Alaour B, Bartkowiak J, Samim D, Praz F, Reineke D, Muller O, Windecker S, Meier D, Pilgrim T

doi: 10.1016/j.jcin.2025.10.005

Thrombosis and Stroke

Edaravone Dexborneol in Large Ischemic Stroke: Real-World Experience from a Multicenter Study in China

J Am Heart Assoc

Ma G, Raynald, Arham A, Jiang Z, Mo R, Zuo Y, Wu Y, Meng S, Lei S, Nguyen TN, Zhong L, EXPAND investigators

doi: 10.1161/JAHA.125.044296

Heart Failure

Prognostic Impact of Cardiovascular-Kidney-Metabolic Overlap Among Patients With Acute Heart Failure: Insights From a Real-World Multinational Cohort

J Am Heart Assoc

Marchetti M, Antiochos P, Pitta-Gros B, Abdurashidova T, Soborun N, Monney P, Yerly P, Tzimas G, Skalidis I, Vollenweider P, Gencer B, Fakhouri F, Vaduganathan M, Hullin R, Lu H

doi: 10.1161/JAHA.125.045294

Atrial Fibrillation

Clinical Impact of Switching From or Persisting With Rivaroxaban or Apixaban After a Bleeding Event: A Real-World Study in Patients With Nonvalvular Atrial Fibrillation

J Am Heart Assoc

Lip GYH, Cheng D, Jiang J, Gao C, Subash R, Vodicka E, Dubey A, Sharma PP, Vettumthara Unnikrishnan A, Mathivanan K, Deitelzweig S

doi: 10.1161/JAHA.125.044113

Related content

Real-World Experience with Selexipag in Patients with Pulmonary Arterial Hypertension: Treatment Patterns and Outcomes across Baseline Risk Strata (SPHERE and EXPOSURE Studies)

Atrial fibrillation recurrence and outcomes in patients with hypertrophic cardiomyopathy: Insights from a nationwide real-world cohort

Valve-in-Valve Transcatheter Mitral Valve Replacement Versus Redo Surgical Mitral Valve Replacement: Meta-Analysis of Early and Late Outcomes

Mavacamten Monotherapy in Real-World Patients with Obstructive Hypertrophic Cardiomyopathy: Evidence From COLLIGO-HCM

Health Status Outcomes 7 Years After Transcatheter or Surgical Aortic Valve Replacement in Low-Surgical Risk Patients With Aortic Stenosis

Real-Time Fluoroscopic Assessment of Underexpansion Predicts Hemodynamic Valve Deterioration Following TAVR With Balloon-Expandable Device

Edaravone Dexborneol in Large Ischemic Stroke: Real-World Experience from a Multicenter Study in China

Prognostic Impact of Cardiovascular-Kidney-Metabolic Overlap Among Patients With Acute Heart Failure: Insights From a Real-World Multinational Cohort

Clinical Impact of Switching From or Persisting With Rivaroxaban or Apixaban After a Bleeding Event: A Real-World Study in Patients With Nonvalvular Atrial Fibrillation